The research about decompression cure IFG and Hypertension

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-11001653

Enrollment

Unknown

Registered

2011-10-31

Start date

2011-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IFG and Hypertension

Interventions

A:Levamlodipine Besylate

B:Losartan

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. The IFG and Hypertension patient; 2. Form eighteen to sixty; 3. The patient accept this clinical trial;

Exclusion criteria

Exclusion criteria: 1. inconformity IFG and Hypertension; 2. Secondary hypertension Patients; 3. Allergy for the trial drug; 4. Gestation?prepare for pregnancy orlactation period; 5. Merging serious disease of heart/lungs/kidney/, or having mental disease. AST passed 2 tines, Cr passed 95umol/L; 6. Researcher think who's unsuited this trial.

Design outcomes

Primary

Measure	Time frame
FPG;OGTT2hPG;INS;OGTT2hINS;HbA1;	—

Countries

China

Contacts

Public ContactWeiping

Wp301@sina.com+86 13983780786

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026